Cardlytics (CDLX) Operating Expenses (2017 - 2025)
Historic Operating Expenses for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $120.9 million.
- Cardlytics' Operating Expenses fell 4393.17% to $120.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $355.2 million, marking a year-over-year decrease of 3913.18%. This contributed to the annual value of $473.8 million for FY2024, which is 650.14% up from last year.
- According to the latest figures from Q3 2025, Cardlytics' Operating Expenses is $120.9 million, which was down 4393.17% from $76.0 million recorded in Q2 2025.
- In the past 5 years, Cardlytics' Operating Expenses registered a high of $465.1 million during Q4 2022, and its lowest value of $32.3 million during Q1 2022.
- Moreover, its 5-year median value for Operating Expenses was $99.7 million (2023), whereas its average is $123.0 million.
- As far as peak fluctuations go, Cardlytics' Operating Expenses surged by 33692.16% in 2022, and later crashed by 5870.28% in 2023.
- Cardlytics' Operating Expenses (Quarter) stood at $106.5 million in 2021, then surged by 336.92% to $465.1 million in 2022, then crashed by 58.7% to $192.1 million in 2023, then tumbled by 57.15% to $82.3 million in 2024, then surged by 46.86% to $120.9 million in 2025.
- Its last three reported values are $120.9 million in Q3 2025, $76.0 million for Q2 2025, and $76.0 million during Q1 2025.